A significant focus for investors is the ongoing Phase 2a clinical study of Immuneering’s lead product, IMM-1-104. This treatment has shown promising results, particularly in combination with other ...
3d
Immuneering (IMRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeffrey ...
Hosted on MSN1mon
IMRX Stock Up on FDA's Orphan Drug Tag for Pancreatic Cancer DrugImage Source: Zacks Investment Research Last month, the company announced positive early response data from the first five patients of an ongoing early to mid-stage study evaluating IMM-1-104 ...
A new study by researchers at the Institute for Environmental Medicine (IMM), Karolinska Institutet shows that there are pronounced sex differences in the incidence rates of psychiatric disorders ...
Two new studies and an accompanying short film have described the experiences of racially minoritized groups with physical and mental health conditions during the pandemic, depicting the inequalities ...
Two new studies and an accompanying short film have described the experiences of racially minoritised groups with physical and mental health ...
(MENAFN- AETOSWire) (BUSINESS WIRE ) -- PharmaJet ® today announced the results of an implementation study in Nigeria that evaluated the impact on coverage, costs, and acceptability of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback